Breaking News Instant updates and real-time market news.

AXGN

AxoGen

$17.56

0.45 (2.63%)

09:22
08/07/19
08/07
09:22
08/07/19
09:22

AxoGen price target lowered to $21 from $29 at BTIG

BTIG analyst Ryan Zimmerman lowered his price target on AxoGen to $21 after its Q2 results and a reset in FY19 guidance to reflect the longer than expected sales scaling. The analyst keeps his Buy rating, noting that the new forecast builds in some buffers to lowered sales rep productivity, but also warns that the stock could be in the "penalty box" given the frequent guidance tweaks until investors have greater confidence about the company's growth rate.

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN AxoGen
$17.56

0.45 (2.63%)

07/12/19
ADAM
07/12/19
INITIATION
Target $32
ADAM
Buy
AxoGen initiated with a Buy at Canaccord
Canaccord analyst Kyle Rose initiated AxoGen with a Buy rating and $32 price target. In a research note to investors, Rose says he believes the investments in the commercial team, market development initiatives and clinical trials position the company to reaccelerate growth into the second half of 2019. Rose says he feels the current valuation represents a compelling entry point, with top-line growth exceeding 30%, a strong balance sheet an an "exceptional" gross margin profile.
08/07/19
CANT
08/07/19
NO CHANGE
Target $21
CANT
Overweight
AxoGen price target lowered to $21 from $30 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou lowered his price target for AxoGen to $21 from $30 after the company reduced its 2019 sales due to delayed productivity growth. While the analyst remains concerned about the trend in top-line growth and the different salesforce issues over the last year, he thinks the revised guidance is achievable. Amid the expected selloff today, Bijou sees a favorable risk/reward on the shares and keeps an Overweight rating on AxoGen.
08/07/19
WBLR
08/07/19
DOWNGRADE
WBLR
Market Perform
AxoGen downgraded to Market Perform from Outperform at William Blair
William Blair analyst Brian Weinstein downgraded AxoGen to Market Perform from Outperform.
08/07/19
WBLR
08/07/19
DOWNGRADE
WBLR
Market Perform
William Blair downgrades AxoGen on another guidance reduction
William Blair analyst Brian Weinstein downgraded AxoGen to Market Perform from Outperform saying he was surprised to hear management "once again" talk down expectations for growth and formally reduce guidance. The company's new outlook reflects an expectation for growth of between 26% and 31% versus a prior target of 30% to 36% growth, Weinstein tells investors in a research note. The issue is delayed productivity growth, which has taken place over the first half of the year as the company undergoes a massive expansion in salesforce, explains the analyst. While he believes the salesforce expansion is warranted and territory splits are common, he thinks the issue will take a few quarters to get ironed out.

TODAY'S FREE FLY STORIES

GS

Goldman Sachs

$216.75

-3.24 (-1.47%)

12:29
09/16/19
09/16
12:29
09/16/19
12:29
Periodicals
Golfman Sachs chief risk officer Vince to retire at end of year, Reuters says »

Goldman Sachs said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 15

    Oct

LMT

Lockheed Martin

$390.15

5.43 (1.41%)

12:27
09/16/19
09/16
12:27
09/16/19
12:27
Periodicals
Greg Ulmer to temporarily run Lockheed aeronautics division, Reuters reports »

Greg Ulmer, head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$14.85

3.03 (25.63%)

12:25
09/16/19
09/16
12:25
09/16/19
12:25
Options
California Resources call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$7.09

0.19 (2.75%)

12:25
09/16/19
09/16
12:25
09/16/19
12:25
Conference/Events
iCAD to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 12

    Nov

CNHI

CNH Industrial

$11.19

-0.01 (-0.09%)

12:21
09/16/19
09/16
12:21
09/16/19
12:21
Periodicals
Elliott builds stake in CNH, sees value in breakup, Bloomberg reports »

Paul Singer's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHE

Chemed

$421.82

0.32 (0.08%)

12:19
09/16/19
09/16
12:19
09/16/19
12:19
Hot Stocks
Chemed subsidiary acquires franchise operater for $120M »

Roto-Rooter Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

  • 20

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
09/16/19
09/16
12:17
09/16/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
09/16/19
09/16
12:16
09/16/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$24.79

-0.32 (-1.27%)

12:15
09/16/19
09/16
12:15
09/16/19
12:15
Options
Adient put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

HLUYY

Lundbeck

$0.00

(0.00%)

, ALDR

Alder Biopharmaceuticals

$18.43

8.38 (83.38%)

12:14
09/16/19
09/16
12:14
09/16/19
12:14
Downgrade
BMO downgrades Alder after buyout, sees another bidder as unlikely »

BMO Capital analyst…

HLUYY

Lundbeck

$0.00

(0.00%)

ALDR

Alder Biopharmaceuticals

$18.43

8.38 (83.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Feb

GM

General Motors

$37.62

-1.21 (-3.12%)

, XOM

Exxon Mobil

$73.74

1.11 (1.53%)

12:08
09/16/19
09/16
12:08
09/16/19
12:08
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are lower and oil…

GM

General Motors

$37.62

-1.21 (-3.12%)

XOM

Exxon Mobil

$73.74

1.11 (1.53%)

CVX

Chevron

$123.81

2.35 (1.93%)

WLL

Whiting Petroleum

$10.42

2.885 (38.31%)

DNR

Denbury Resources

$1.54

0.33 (27.27%)

XOG

Extraction Oil & Gas

$3.95

0.725 (22.52%)

CDEV

Centennial Resource Development

$5.62

1.21 (27.44%)

ALDR

Alder Biopharmaceuticals

$18.42

8.37 (83.28%)

SEMG

SemGroup

$16.79

6.51 (63.33%)

ET

Energy Transfer LP

$13.52

-0.49 (-3.50%)

NEWR

New Relic

$54.62

-3.72 (-6.38%)

LL

Lumber Liquidators

$9.12

-0.65 (-6.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 08

    Oct

  • 09

    Oct

  • 07

    Nov

  • 13

    Nov

  • 21

    Feb

MGM

MGM Resorts

$28.82

-0.22 (-0.76%)

, BX

Blackstone

$53.49

-0.06 (-0.11%)

12:07
09/16/19
09/16
12:07
09/16/19
12:07
Periodicals
Blackstone in talks to buy Bellagio and MGM Grand, Bloomberg reports »

Blackstone Group (BX) is…

MGM

MGM Resorts

$28.82

-0.22 (-0.76%)

BX

Blackstone

$53.49

-0.06 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 26

    Sep

CEO

Cnooc

$162.07

10.57 (6.98%)

12:05
09/16/19
09/16
12:05
09/16/19
12:05
Upgrade
Cnooc rating change  »

Cnooc upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$41.87

0.06 (0.14%)

12:05
09/16/19
09/16
12:05
09/16/19
12:05
Conference/Events
Boston Scientific participates in a conference call with SVB Leerink »

Conference call with SVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 13

    Nov

NEWR

New Relic

$53.86

-4.48 (-7.68%)

12:01
09/16/19
09/16
12:01
09/16/19
12:01
Recommendations
New Relic analyst commentary  »

New Relic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$16.91

-1.94 (-10.29%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -10.2% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCO

Scor ADR

$13.52

-3.825 (-22.06%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Scor ADR falls -21.8% »

Scor ADR is down -21.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$4.37

-2.11 (-32.56%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Britannia Bulk falls -32.8% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$14.50

2.68 (22.67%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
California Resources rises 22.6% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$10.27

2.74 (36.39%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Whiting Petroleum rises 36.5% »

Whiting Petroleum is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

  • 09

    Oct

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.31

0.16 (0.18%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Options
Puts lead calls 15:1 in High Yield Bond ETF on vertical spread buyer »

Puts lead calls 15:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEMG

SemGroup

$16.82

6.54 (63.62%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
SemGroup rises 63.6% »

SemGroup is up 63.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:00
09/16/19
09/16
12:00
09/16/19
12:00
General news
Treasury's $87 B 3- and 6-month bill auction results were generally below average »

Treasury's $87 B 3-…

VLGEA

Village Super Market

$26.70

0.05 (0.19%)

11:53
09/16/19
09/16
11:53
09/16/19
11:53
Hot Stocks
Village Super Market board of directors authorizes $5M share repurchase program »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$52.62

0.875 (1.69%)

11:51
09/16/19
09/16
11:51
09/16/19
11:51
Upgrade
Total rating change  »

Total upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.